Short communication · 2021
Byline
M. Socinski
Articles whose byline reads M. Socinski, printed as Mark A Socinski. Different authors can share a byline.
- Articles
- 7
- Latest year
- 2021
Articles
Newest first. Showing 1–7 of 7 articles.
Research article · 28 Aug 2020
Oral Poziotinib shows clinical activity and durable response in previously treated EGFR exon 20 NSCLC patients a phase 2 study
Conference abstract · 18 Mar 2020
Oral Poziotinib shows clinical activity and durable response in previously treated EGFR exon 20 NSCLC patients –a phase 2 study
Conference abstract · 1 Mar 2020
Respiratory 2020: Oral Poziotinib shows clinical activity and durable response in previously treated EGFR exon 20 NSCLC patients âÂ?Â?a phase 2 study- Mark A Socinski, Spectrum Pharmaceuticals Inc.
Conference abstract · 2020
Respiratory 2020: Oral Poziotinib shows clinical activity and durable response in previously treated EGFR exon 20 NSCLC patients –a phase 2 study- Mark A Socinski, Spectrum Pharmaceuticals Inc.
Short communication · 2019
Oral Poziotinib shows clinical activity and durable response in previously treated EGFR exon 20 NSCLC patientsâ?? a phase2 study
Short communication · 2019
